SeouLinBioscienceCO.,LTD.
038070 | KO
Overview
Corporate Details
- ISIN(s):
- KR7038070009
- LEI:
- Country:
- South Korea
- Address:
- 경기도 성남시 분당구 삼평동 694-1 코리아바이오파크(KOREA BIO PARK) A동 4층, 성남시
- Website:
- N/A
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-14 00:00 |
Interim / Quarterly Report
반기보고서 (2025.06)
|
Korean | 1.7 MB | ||
| 2025-06-13 00:00 |
Share Issue/Capital Change
증권발행결과(자율공시)
|
Korean | 5.6 KB | ||
| 2025-06-11 00:00 |
Capital/Financing Update
주요사항보고서(전환사채권발행결정)
|
Korean | 88.9 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.6 MB | ||
| 2025-04-09 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
|
Korean | 64.6 KB | ||
| 2025-04-01 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | ||
| 2025-04-01 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | ||
| 2025-04-01 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.1 KB | ||
| 2025-03-26 00:00 |
AGM Information
정기주주총회결과
|
Korean | 25.3 KB | ||
| 2025-03-18 00:00 |
Audit Report / Information
감사보고서제출
|
Korean | 25.3 KB | ||
| 2025-03-18 00:00 |
Audit Report / Information
[첨부추가]사업보고서 (2024.12)
|
Korean | 561.6 KB | ||
| 2025-03-10 00:00 |
Earnings Release
[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 16.0 KB | ||
| 2025-03-10 00:00 |
Pre-Annual General Meeting Information
주주총회소집공고
|
Korean | 223.4 KB | ||
| 2025-03-10 00:00 |
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
|
Korean | 222.4 KB | ||
| 2025-02-20 00:00 |
Pre-Annual General Meeting Information
주주총회소집결의
|
Korean | 11.7 KB |
Automate Your Workflow. Get a real-time feed of all SeouLinBioscienceCO.,LTD. filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for SeouLinBioscienceCO.,LTD.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for SeouLinBioscienceCO.,LTD. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Develops patented nanotechnology for oncology and transplantology diagnostics and therapies.
Poland
NNG
Poland
NNG
Biotech IP generator developing and licensing mRNA therapeutics using proprietary delivery systems.
Japan
4571
Japan
4571
Developing biomimetic nanomachines as broad-spectrum drugs to neutralize viral infections.
United States of America
NNVC
United States of America
NNVC
Developing a proteomics platform for single-molecule analysis to advance life sciences research.
United States of America
NAUT
United States of America
NAUT
Develops NT-I7, a T cell-amplifying immunotherapy for cancer and infectious diseases.
United States of America
950220
United States of America
950220
Develops immunotherapy vaccines for autoimmune diseases & invests in BioTech/MedTech companies.
France
ALNEV
France
ALNEV
Developing oral LDL-lowering therapies for high-risk cardiovascular disease patients.
United States of America
NAMS
United States of America
NAMS
R&D of biotech medical devices for diabetes care and topical skin treatments.
Israel
NXGN
Israel
NXGN
Develops botanical drug candidates to treat smoking and alcohol addictions.
France
ALNFL
France
ALNFL